Devonian Health Group Inc.
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis as… Read more
Market Cap & Net Worth: Devonian Health Group Inc. (DVHGF)
Devonian Health Group Inc. (OTCQB:DVHGF) has a market capitalization of $397.43K ($397.43K) as of March 19, 2026. Listed on the OTCQB stock exchange, this USA-based company holds position #38188 globally and #12428 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Devonian Health Group Inc.'s stock price $0.14 by its total outstanding shares 2765725 (2.77 Million).
Devonian Health Group Inc. Market Cap History: 2025 to 2025
Devonian Health Group Inc.'s market capitalization history from 2025 to 2025. Data shows growth from $397.43K to $397.43K (0.00% CAGR).
Devonian Health Group Inc. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Devonian Health Group Inc.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.02x
Devonian Health Group Inc.'s market cap is 0.02 times its annual revenue
1740.90x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $397.43K | $23.59 Million | -$6.01 Million | 0.02x | N/A |
Competitor Companies of DVHGF by Market Capitalization
Companies near Devonian Health Group Inc. in the global market cap rankings as of March 19, 2026.
Key companies related to Devonian Health Group Inc. by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #165 globally with a market cap of $114.33 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #285 globally with a market cap of $73.32 Billion USD.
- CSL Limited (PINK:CMXHF): Ranked #340 globally with a market cap of $63.46 Billion USD.
- argenx SE (OTCGREY:ARGNF): Ranked #497 globally with a market cap of $42.99 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #165 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $114.33 Billion | $451.59 |
| #285 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $73.32 Billion | $744.12 |
| #340 | CSL Limited | PINK:CMXHF | $63.46 Billion | $149.87 |
| #497 | argenx SE | OTCGREY:ARGNF | $42.99 Billion | $697.42 |
Devonian Health Group Inc. Historical Marketcap From 2025 to 2025
Between 2025 and today, Devonian Health Group Inc.'s market cap moved from $397.43K to $ 397.43K, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $397.43K | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Devonian Health Group Inc. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $397.43K USD |
| MoneyControl | $397.43K USD |
| MarketWatch | $397.43K USD |
| marketcap.company | $397.43K USD |
| Reuters | $397.43K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.